OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Pathology is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Intravenous iron treatment fuels chronic kidney disease‐induced arterial media calcification in rats	93
High‐resolution and quantitative spatial analysis reveal intra‐ductal phenotypic and functional diversification in pancreatic cancer	81
Breathing in danger: how particulate matter pollution is putting the public at risk of lung cancer^†	72
Novel prognostication biomarker adipophilin reveals a metabolic shift in uveal melanoma and new therapeutic opportunities	69
CXCR4 mediates leukemic cell migration and survival in the testicular microenvironment	68
The association between the tumor immune microenvironments and clinical outcome in low‐grade, early‐stage endometrial cancer patients	66
Issue Information	64
Ovarian high‐grade serous carcinoma cells with low SMARCA4 expression and high SMARCA2 expression contribute to platinum resistance	60
Spatial profiling of ANO7 in prostate tissue: links to AR‐signalling‐associated lipid metabolism and inflammation	57
A new FGF15/19‐mediated gut‐to‐heart axis controls cardiac hypertrophy	56
Collagen VI promotes recovery from colitis by inducing lymphangiogenesis and drainage of inflammatory cells	53
Artificial intelligence to identify genetic alterations in conventional histopathology	51
Presence of Tim3⁺ and PD‐1⁺CD8⁺T cells identifies microsatellite stable colorectal carcinomas with immune exhaustion and di	50
‘Know thyself’ – host factors influencing cancer response to immune checkpoint inhibitors	50
Integration of peripheral blood‐ and tissue‐based biomarkers of response to immune checkpoint blockade in urothelial carcinoma	48
Escape from senescence: molecular basis and therapeutic ramifications	46
Integrating computational pathology and proteomics to address tumor heterogeneity	43
CRISPR–Cas9 screening identifies the role of FER as a tumor suppressor	43
Identification of tumour‐infiltrating myeloid subsets associated with overall survival in lung squamous cell carcinoma	42
Platelet C3G protects from liver fibrosis, while enhancing tumor growth through regulation of the immune response	42
The E2F1–HOXB9/PBX2–CDK6 axis drives gastric tumorigenesis and serves as a therapeutic target in gastric cancer	38
Pseudobudding: ruptured glands do not represent true tumor buds	38
Human scattered tubular cells represent a heterogeneous population of glycolytic dedifferentiated proximal tubule cells	38
In high‐grade ovarian carcinoma, platinum‐sensitive tumor recurrence and acquired‐resistance derive from quiescent residual cancer cells that overexpress CRYAB, CEACAM6, and	35
Silencing GRHL3 promotes multiple organ distant metastasis of lung squamous cell carcinoma cells by enhancing SOX2 stability via SIRT1	35

Genomic features of Helicobacter pylori‐naïve diffuse‐type gastric cancer	34
	34
Field cancerization in breast cancer	33
	33
Prediction of coexisting invasive carcinoma on ductal carcinoma in situ (DCIS) lesions by mass spectrometry imaging	32
Adrenomedullin2 stimulates progression of thyroid cancer in mice and humans under nutrient excess conditions	32
Development of a multi‐scanner facility for data acquisition for digital pathology artificial intelligence	31
Minigene‐based splicing analysis and ACMG/AMP‐based tentative classification of 56 ATM variants	31
Integrative analysis of genomic and transcriptomic data of normal, tumour, and co‐occurring leukoplakia tissue triads drawn from patients with gingivobuccal oral cancer identifies signatures of tumour	31